Cargando…

Cancer symptom control trials: how may we advance this field?

Detalles Bibliográficos
Autor principal:	MacDonald, N.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Updates and Developments in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899359/ https://www.ncbi.nlm.nih.gov/pubmed/17593980

Ejemplares similares

Cancer and thrombosis: recent advances
por: Solymoss, S.
Publicado: (2008)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?
por: Gainford, M.C., et al.
Publicado: (2006)

The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)

Role of vaccine therapy in cancer: biology and practice
por: Schlom, J., et al.
Publicado: (2007)

Anal cancer and human papillomaviruses in heterosexual men
por: Nyitray, A.
Publicado: (2008)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

Targeting transforming growth factor β to enhance cancer immunotherapy
por: Hahn, T., et al.
Publicado: (2006)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics
por: Williams, P.D., et al.
Publicado: (2009)

Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007)

Radiation oncology: Times of practice change
por: Freeman, C.R., et al.
Publicado: (2007)

Radiofrequency ablation and cryoablation of renal tumours
por: Kwan, K.G., et al.
Publicado: (2007)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008)

Electrochemotherapy of tumours
por: Sersa, G., et al.
Publicado: (2009)

Exosomes in tumour immunity
por: Clayton, A., et al.
Publicado: (2009)

Retinoids, vitamin D, invasion, and metastasis
por: Tokar, E.J., et al.
Publicado: (2006)

Tissue‐specific mechanisms of alternative polyadenylation: Testis, brain, and beyond (2018 update)
por: MacDonald, Clinton C.
Publicado: (2019)

Pragmatic cluster randomized trial to evaluate effectiveness and implementation of EHR-facilitated collaborative symptom control in cancer (E2C2): addendum
por: Herrin, Jeph, et al.
Publicado: (2023)

Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial
por: Ashraf, Sohaib, et al.
Publicado: (2022)

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease
por: Cummings, J, et al.
Publicado: (2015)

Microbes and colorectal cancer: is there a relationship?
por: Uronis, J.M., et al.
Publicado: (2009)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
por: Privé, Bastiaan M., et al.
Publicado: (2021)

Statistical analysis plan for the control of blood pressure and risk attenuation-rural Bangladesh, Pakistan, Sri Lanka (COBRA-BPS) trial: a cluster randomized trial for a multicomponent intervention versus usual care in hypertensive patients
por: Gandhi, Mihir, et al.
Publicado: (2018)

Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial—an update to the published protocol
por: Norton, Christine
Publicado: (2023)

Editorial Comment: Techniques - Ultrasound-guided percutaneous nephrolithotomy: How we do it
por: Danilovic, Alexandre
Publicado: (2020)

Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial
por: Bairavi, Joann, et al.
Publicado: (2023)

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan
por: Lo, Serigne N., et al.
Publicado: (2020)

Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
por: Eltoft, Agnethe, et al.
Publicado: (2022)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020)

A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial
por: Brakenhoff, Timo B., et al.
Publicado: (2021)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
por: Al-Shahi Salman, Rustam, et al.
Publicado: (2019)

Lessons learnt during a complex, multicentre cluster randomised controlled trial: the ProAct65+ trial
por: Stevens, Zoe, et al.
Publicado: (2013)

Statistical analysis plan for the PlAtelet Transfusion in Cerebral Haemorrhage (PATCH) trial: a multicentre randomised controlled trial
por: Baharoglu, M. Irem, et al.
Publicado: (2016)

Statistical analysis plan for the Surgery for Cancer with Option of Palliative Care Expert (SCOPE) trial: a randomized controlled trial of a specialist palliative care intervention for patients undergoing surgery for cancer
por: Orun, Onur M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7g0t8e7b2ctodqqtv4gssrlono